Síndrome de ovario poliquístico como factor predisponente en enfermedades cardio metabólicas

Abstract

In recent years, polycystic ovary syndrome (PCOS) has emerged as a severe and highly prevalent endocrinopathy, affecting up to 3.4% of women aged 15 to 49 years worldwide, according to data released by the World Health Organization (WHO). Its complexity lies in the fact that these patients are more likely to develop severe cardiometabolic complications at an early age, which raises annual mortality rates in this population. Objective: To describe polycystic ovary syndrome as a predisposing factor for cardiometabolic diseases. Methods: An integrative qualitative approach was used for this descriptive and non-experimental bibliographic review. It focused on collecting literature published in the last five years from the primary scientific databases. Results: This study included 55 publications, in line with the proposed objectives and inclusion criteria. Conclusions: This review revealed that PCOS is a public health problem closely related to hyperinsulinemia and insulin resistance. It can develop metabolic diseases that include Diabetes Mellitus Type 2, dyslipidemia, metabolic syndrome, and obesity, as well as cardiac conditions like stroke, coronary artery disease, acute myocardial infarction, and hypertension.